Pharmacological Characterization of the Selective, Orally Bioavailable, Potent Dual PI3K/mTORC1/2 Inhibitor PQR530Petra Hillmann,Denise Rageot,Florent Beaufils,Anna Melone,Alexander Sele,Robert A. Ettlin,Jürgen Mestan,Vladimir Cmiljanovic,Marc Lang,Elisabeth Singer,Carolin Walter, Hoa HP Nguyen,Paul Hebeisen,Matthias P. Wymann,Doriano FabbroCancer Research（2017）引用 1|浏览34AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
